US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

243.73

+3.321.38%

Pre-market: 243.72-0.00640.00%07:31 EDT

Volume:10K

Turnover:2.39M

Market Cap:481.73M

PE:- -

High:244.35

Open:240.22

Low:240.22

Close:240.41

52wk High:244.35

52wk Low:160.91

Shares:1.98M

Float Shares:1.98M

Volume Ratio:0.71

T/O Rate:0.50%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement

Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference

Regeneron Announces Investor Conference Presentations

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

US FDA Approves Regeneron's Rare Bone Disorder Drug

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS

Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS

Why 2026 is Biotech's Comeback Year

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS

What This Top Biotech Fund is Buying Now

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares

TScan Therapeutics Faces Loss of Key Amgen Partnership

TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing

THOMSON REUTERS

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

BMO starts Exelixis at Market Perform into patent cliff

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":243.7264,"timestamp":1787688000000,"preClose":240.41,"halted":0,"volume":9843,"hourTrading":{"tag":"盘前","latestPrice":243.72,"preClose":243.7264,"latestTime":"07:31 EDT","volume":3,"amount":731.16,"timestamp":1787743861123,"change":-0.0064,"changeRate":-0.000026,"amplitude":0},"delay":0,"changeRate":0.013794767272576081,"floatShares":1976503,"shares":1976503,"eps":0,"marketStatus":"Pre-Mkt","change":3.3164,"latestTime":"08-26 09:22:38 EDT","open":240.22,"high":244.345,"low":240.22,"amount":2394036.2130299998,"amplitude":0.017158,"askPrice":365.58,"askSize":101,"bidPrice":220,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":243.7264,"sharesOutstanding":1976503,"nav":240.10472,"aum":474567706.07,"dividendRate":0.0039,"bidAskSpread":0.00128,"preHourTrading":{"tag":"盘前","latestPrice":243.72,"preClose":243.7264,"latestTime":"07:31 EDT","volume":3,"amount":731.16,"timestamp":1787743861123,"change":-0.0064,"changeRate":-0.000026,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":243.48,"preClose":243.7264,"latestTime":"19:30 EDT","volume":15,"amount":3655.9176,"timestamp":1787700602077,"change":-0.2464,"changeRate":-0.001011,"amplitude":0},"volumeRatio":0.7131678430215547,"impliedVol":0.2069,"impliedVolPercentile":0.72},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1976503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7131678430215547,"shares":1976503,"dividePrice":0.9505,"high":244.345,"amplitude":0.017158,"preClose":240.41,"low":240.22,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":243.7264,"committee":-0.004975,"eps":0,"divideRate":0.0039,"volume":9843,"delay":0,"ttmEps":0,"open":240.22,"prevYearClose":189.2649,"prevWeekClose":241.2282,"prevMonthClose":205.5494,"prevQuarterClose":203.2373,"fiveDayClose":224.4799,"twentyDayClose":210.0993,"sixtyDayClose":188.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNX","GILD","BIB","IE00BSNM7G36.USD","LU1674673428.USD","BK4583","MRNY","LU1934455863.HKD","IE00B19Z3B42.SGD","IBBQ","MEDI","BK4588","SG9999015978.USD","LU0320765992.SGD","LU0861579265.USD","LU0965508806.USD","IE0002270589.USD","LU0965509101.SGD","LU1430594728.SGD","LU0889565916.HKD","SG9999015952.SGD","BK4548","LU0289739699.SGD","LU2324357040.USD","LU0234570918.USD","LU1934455194.USD","LU0965509010.AUD","BK4139","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1585245621.USD","MRNA","BBH","LU0965509283.SGD","LU1934455277.USD","IBB","IDNA","LGHT","LU0122379950.USD","BMED","BK4578","GNOM","TBXU","TMED","LU1778281490.HKD","WDNA","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473673","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473673","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473673?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:15","pubTimestamp":1787170546,"startTime":"0","endTime":"0","summary":"• Vertex stock surged to record highs following a rival's clinical trial failure.\n• Q2 revenue beat estimates, and the company raised its full-year guidance.\n• Analysts issued bullish ratings with an average price target of $563.25.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262119122-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2362541513.USD","PBE","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","LU2324357040.USD","IE00B894F039.SGD","SG9999001176.USD","BK4585","TBXU","LU1674673691.USD","BK4567","LU0889565916.HKD","LU1093756325.SGD","BBH","IBBQ","IE00BZ9MQY76.HKD","LU0061475181.USD","LU2236285917.USD","SGXZ57979304.SGD","LU0432979614.USD","IE00B19Z9Z06.USD","LU1430594728.SGD","LU2417539215.USD","IE00B19Z3B42.SGD","BIB","VRTX","IE00B19Z3581.USD","LU0823416689.USD","LU2237438978.USD","LU2362541273.HKD","IE0002270589.USD","LU2462157665.USD","LU2362540622.SGD","IDNA","LU1585245621.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1035775433.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","IE00B19Z9P08.USD","BK4533","IE00B2B36J28.USD","LU1778281490.HKD","LU0417517546.SGD","LU2456880835.USD","BK4532","BK4588","LU2468319806.SGD","LU0234570918.USD","LU1674673428.USD","LU2089984988.USD","GNMX","IBB","IE00BJT1NW94.SGD","LU0109394709.USD","LU0289739699.SGD","LU0058720904.USD","LU1069344957.HKD","LU1093756168.USD","LU0079474960.USD","SG9999001176.SGD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660647872","title":"Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2660647872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660647872?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:06","pubTimestamp":1787169960,"startTime":"0","endTime":"0","summary":"Regeneron to webcast management presentation at Wells Fargo Healthcare ConferenceRegeneron to present at the 2026 Wells Fargo Healthcare Conference on Sept. 9, 2026 at 8:45 a.m. ET.Management to appea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL2xh7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BQXX3F31.USD","LU0058720904.USD","LU1917777945.USD","IBB","REGN","BCDF","LU2095319765.USD","BK4588","LU2362541273.HKD","TBXU","IE00B64PRP62.GBP","LU2106854487.HKD","BBH","LU2362540622.SGD","SG9999014005.SGD","NDAQ","LU2237438978.USD","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","LU0114720955.EUR","LU0289739699.SGD","IBBQ","LU0823434583.USD","IE00BN0W2T93.GBP","LU0889565916.HKD","LU0053666078.USD","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU1974910355.USD","LU0320765992.SGD","LU0823416689.USD","IE00B3QW5Z07.USD","LU0314104364.USD","LU0823434740.USD","LU2468319806.SGD","SG9999014039.USD","LU0109394709.USD","LU2210149790.SGD","SG9999014013.SGD","LU0882574055.USD","LU2023250504.SGD","BK4139","IE00BQXX3D17.EUR","BK4112","LU2362541513.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473213","title":"Regeneron Announces Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473213","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473213?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169900,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Aug.  19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347966/0/en/regeneron-announces-investor-conference-presentations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU2468319806.SGD","LU0320765992.SGD","LU2362540622.SGD","LU0289739699.SGD","IBBQ","TBXU","LU1974910355.USD","LU2237438978.USD","LU0109394709.USD","LU0889565916.HKD","BK4585","LU2089984988.USD","LU0823434583.USD","LU0823434740.USD","REGN","BK4139","LU2023250504.SGD","LU1917777945.USD","LU0053666078.USD","BBH","BK4588","IBB","LU0058720904.USD","LU0823416689.USD","LU0882574055.USD","LU2106854487.HKD","LU2362541513.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660742032","title":"Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660742032","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660742032?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:27","pubTimestamp":1787164025,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  has received approval from the US Food and Drug Administration for Pasatru to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, or FOP, the drugmaker said Wednesday.FOP is an ultra-rare genetic disorder in which rogue bone formation progressively infiltrates muscles, tendons, ligaments and other connective tissues, causing loss of mobility and potentially making basic activities such as walking, eating and breathing difficult, the company said.The approval was based on phase 3 OPTIMA trial results showing Pasatru reduced new heterotopic ossification lesions by 90% at the 10 mg per kg dose and 94% at the 3 mg per kg dose versus placebo at 56 weeks, the company said.Clinician-assessed flare-ups fell 88% with the 10 mg/kg dose and 15% with the 3 mg per kg dose, the company said.Price: 840.95, Change: +30.71, Percent Change: +3.79","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0114720955.EUR","LU2237438978.USD","TBXU","LU0053666078.USD","LU2023250504.SGD","BBH","LU0823434583.USD","LU0823416689.USD","IBB","LU2362541513.USD","LU2468319806.SGD","LU0882574055.USD","LABU","LU0058720904.USD","IBBQ","LU0289739699.SGD","LU2362541273.HKD","BK4139","LU2089984988.USD","REGN","LU1974910355.USD","LU1917777945.USD","LU2106854487.HKD","LU0109394709.USD","LU2362540622.SGD","LU0320765992.SGD","LU0889565916.HKD","LU0823434740.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420810","title":"Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420810","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660420810?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:15","pubTimestamp":1787163346,"startTime":"0","endTime":"0","summary":"• Argus raised Amgen's price target and reiterated a Buy rating.\n• Second-quarter financial performance exceeded Wall Street revenue and earnings expectations.\n• Technical indicators show a MACD buy signal and RSI buy condition.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118745-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","BK4534","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999001440.SGD","LU0889565916.HKD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","PBE","LU2089984988.USD","TBXU","LU1061106388.HKD","BBH","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","04332","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660272694","title":"US FDA Approves Regeneron's Rare Bone Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660272694","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660272694?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162562,"startTime":"0","endTime":"0","summary":"US FDA approves Regeneron's rare bone disorder drugAug 19-The U.S. Food and Drug Administration on Wednesday approved Regeneron'sREGN.Oexperimental treatment fora rare genetic disorder after the drug significantly reduced abnormal bone formation in certain soft tissues.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G1JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBBQ","LU1974910355.USD","LU0320765992.SGD","REGN","TBXU","LU2362541513.USD","LU0889565916.HKD","LU2023250504.SGD","LU2237438978.USD","LU2468319806.SGD","LU1917777945.USD","BK4588","BK4585","LU0823434583.USD","LU0882574055.USD","LU2106854487.HKD","LU2089984988.USD","LU0289739699.SGD","LU0053666078.USD","LU2362540622.SGD","LU0823416689.USD","LU0823434740.USD","LU0058720904.USD","LU2362541273.HKD","LU0114720955.EUR","IBB","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660264427","title":"Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660264427","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660264427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162537,"startTime":"0","endTime":"0","summary":"Regeneron says FDA approves Pasatru for adults with rare bone disorder FOPRegeneron won FDA clearance for Pasatru (garetosmab-grts) to curb new HO lesions, clinician-assessed flare-ups in adults with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLKHCsC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0823434740.USD","LU0889565916.HKD","LU0823434583.USD","LU2362541513.USD","LU0109394709.USD","IBB","REGN","BK4139","LU0882574055.USD","LU0823416689.USD","LU1917777945.USD","LU0320765992.SGD","IBBQ","BK4585","BK4588","LU0289739699.SGD","LU2362540622.SGD","LU0114720955.EUR","LU2362541273.HKD","LU2468319806.SGD","LU1974910355.USD","LU0053666078.USD","LU0058720904.USD","BBH","LU2237438978.USD","TBXU","LU2106854487.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427109","title":"Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427109?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU1917777945.USD","LU2468319806.SGD","LU2089984988.USD","LU0823434740.USD","TBXU","LU1974910355.USD","BK4588","LU0823434583.USD","LU0289739699.SGD","LU0109394709.USD","LU2023250504.SGD","BK4585","BK4139","LU0053666078.USD","LU2106854487.HKD","IBB","LU0058720904.USD","IBBQ","LU2362541273.HKD","LU2362541513.USD","LU0114720955.EUR","LU2362540622.SGD","REGN","LU2237438978.USD","LU0320765992.SGD","BBH","LU0823416689.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427103","title":"Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427103?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","BK4139","BK4588","LU2237438978.USD","LU2362541513.USD","LU0823434740.USD","LU2023250504.SGD","LU0823434583.USD","LU2089984988.USD","LU2362541273.HKD","LU2468319806.SGD","LU0114720955.EUR","LU1917777945.USD","LU0320765992.SGD","IBBQ","LU0289739699.SGD","REGN","TBXU","LU2106854487.HKD","LU1974910355.USD","BK4585","IBB","LU0889565916.HKD","LU2362540622.SGD","LU0058720904.USD","BBH","LU0823416689.USD","LU0053666078.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421798","title":"Why 2026 is Biotech's Comeback Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421798","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421798?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:16","pubTimestamp":1787152560,"startTime":"0","endTime":"0","summary":"This article was originally published on April 1, 2026. It has been updated to reflect recent developments.After a rough past few years, the biotech sector looks to be turning a corner. Major pharmace","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1691799644.USD","BK4534","XLV","LU1280957306.USD","PBE","LU2168564495.EUR","LU2324357040.USD","LU2112291526.USD","LU2746668461.USD","LU1267930730.SGD","THNR","WDNA","LLII","LU0820562030.AUD","LU0889565916.HKD","LU0061475181.USD","IBBQ","LU0354030438.USD","LU2271345857.HKD","SGXZ57979304.SGD","LU0109391861.USD","IE0004445239.USD","IE00BWXC8680.SGD","SG9999014906.USD","LU1232071149.USD","LU2089283258.USD","IE00BN29S564.USD","IE00B4JS1V06.HKD","LU2237438978.USD","SGXZ81514606.USD","LU1551013342.USD","MRNY","GDOC","BK4566","LU0097036916.USD","IE00B1BXHZ80.USD","LU1629891620.HKD","LU2237443549.SGD","SG9999018865.SGD","LU1720051017.SGD","LU2237443465.HKD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU2237443895.HKD","LU2264538146.SGD","HRTS","LU1127390331.HKD","LU1291159041.SGD","SG9999014880.SGD","IE0005OL40V9.USD","LU0106261372.USD","LU2168564149.EUR","LU2265009873.SGD","IYH","LU0198837287.USD","LU2237443382.USD","LU2750360997.AUD","LU1868836914.USD","LU2471134796.USD","IBB","LU1069344957.HKD","LU0256863902.USD","LU1712237335.SGD","IE0001KFT4U8.USD","TMED","SG9999013999.USD","LU0203202063.USD","LLYZ","LU2471134523.USD","IE0004445015.USD","SG9999017495.SGD","AMGN","RXL","LU1064131342.USD","FTXH","LU2168564222.USD","PJP","LU0672654240.SGD","LU2462591350.SGD","LU2360106947.USD","OZEM","LU0689472784.USD","LU1974910355.USD","LU0225283273.USD","LU2417539215.USD","LU2211815571.USD","LU1988902786.USD","BIB","SG9999015986.USD","LU2023250330.USD","BK4551","BK4568","IE00BK4W5L77.USD","LU2237443622.USD","LU0943347566.SGD","LU0114720955.EUR","LU0823416689.USD","LU0964807845.USD","LU2602419157.SGD","LU0154236417.USD","LU0385154629.USD","LU2491049909.HKD","NVOH","BK4599","BK4501","LU2462157665.USD","ELIS","LU0353189763.USD","IE00BK4W5M84.HKD","LU1868837300.USD","LU2028103732.USD","LU0316494557.USD","LU2491050071.SGD","BK4548","LU2213496289.HKD","IE00BJJMRY28.SGD","LU0823434583.USD","SG9999014914.USD","LU0820561909.HKD","IE00BKDWB100.SGD","LU0203201768.USD","BK4532","LU2063271972.USD","IXJ","LU0345770308.USD","LU0882574055.USD","LU1323610961.USD","IE00BJT1NW94.SGD","CANC","LU0109394709.USD","LU1093756168.USD","LU0708995401.HKD","LU2089284900.SGD","LU0882574139.USD","LU2106854487.HKD","SG9999001176.SGD","SGXZ31699556.SGD","LU2461242641.AUD","IE00BJJMRX11.SGD","MRNA","CURE","JDOC","04332","AGNG","LU2108987350.USD","LU2756315318.SGD","LU0158827781.USD","NVO","TRUH","LU0133085943.USD","TBXU","BK4585","LU1366192091.USD","LU0466842654.USD","LU2242652126.USD","LU2552382058.USD","LU1868837136.USD","LU0323591593.USD","VHT","LU2168563687.JPY","MHIP","LU1057294990.SGD","LU2023250504.SGD","IE00B7KXQ091.USD","LU2168564065.EUR","LU2361044949.HKD","MEDI","LU1551013425.SGD","BK4007","IE00BKVL7J92.USD","LU1720051108.HKD","LU0266013472.USD","LU2552382215.SGD","LU0456855351.SGD","SG9999014898.SGD","IE00B1XK9C88.USD","LU2242646821.SGD","LU1145028129.USD","LU1035775433.USD","LGHT","IE00BZ1G4Q59.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU2237443978.SGD","BK4533","LU0471298777.SGD","LU0787776722.HKD","LU0868494617.USD","LU1571399168.USD","LU2491050154.USD","ILDR","LLY","LU0122379950.USD","LU0417517546.SGD","LU0238689110.USD","LU2456880835.USD","LU2552382132.HKD","LU1023059063.AUD","LU2361044865.SGD","LU0058720904.USD","IE00B775H168.HKD","LU2471134879.HKD","LU0079474960.USD","LU0158827948.USD","MEDX","LU0683600562.USD","PPH","LU2896262040.SGD","SG9999015945.SGD","LU0320765992.SGD","LU1868836757.USD","LU0345770993.USD","LU2357305700.SGD","LU2111349929.HKD","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJLML261.HKD","LU0234572021.USD","SG9999001176.USD","SGXZ99366536.SGD","LLYX","LU0006306889.USD","LU2361045086.USD","LU0320765059.SGD","IHE","LU1093756325.SGD","BBH","LU2087625088.SGD","LU0354030511.USD","LU2750360641.GBP","NVOX","LU2236285917.USD","LU0094547139.USD","SG9999015952.SGD","LU1989771016.USD","LU0432979614.USD","LU1548497426.USD","LU1804176565.USD","LU2756315664.SGD","LU0174119429.USD","FHLC","LU1623119135.USD","IE00BFSS7M15.SGD","LU0640476718.USD","GB00BDT5M118.USD","LU0786609619.USD","LU2023251221.USD","LU1979441026.SGD","IDNA","LU1814569148.SGD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BKPKM429.USD","GNOM","LU1983299246.USD","SG9999015978.USD","ELIL","IE00B2B36J28.USD","SG9999018857.SGD","SGXZ51526630.SGD","LU0471298694.HKD","BK4588","LU0353189680.USD","LU1917777945.USD","LU2468319806.SGD","LU2089984988.USD","LU0820561818.USD","LU0289739699.SGD","LU1868836591.USD","MRNX","SG9999001440.SGD","LU1061106388.HKD","LU0210536198.USD","LU2471134952.CNY","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426691","title":"Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426691?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:45","pubTimestamp":1787147100,"startTime":"0","endTime":"0","summary":"DJ Merck, Amgen Share Gains Contribute To Dow's 161-Point ClimbThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck and Amgen are posting positive gains Wednesday morning, lifting the Dow Jones Industrial Average into positive territory.Shares of Merck  and Amgen  have contributed to the blue-chip gauge's intraday rally, as the Dow  was most recently trading 161 points higher .Merck's shares have climbed $12.37  while those of Amgen are up $13.30 , combining for an approximately 153-point bump for the Dow.Other components contributing significantly to the gain include Sherwin-Williams Co. , Home Depot , and Salesforce .A $1 move in any one of the 30 components of the benchmark results in a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDOW","04332","LU0106261372.USD","IE000M9KFDE8.USD","LU0208291251.USD","LU1066051811.HKD","LU0203345920.USD","BIB","LU1585245621.USD","LU1116320901.HKD","SG9999001440.SGD","XLV","IE00BLSP4452.SGD","JDOC","LU0859254822.USD","LU2491050071.SGD","MGK","LU1974910355.USD","LU0265550946.USD","LU1037948541.HKD","LU0320765992.SGD","SDY","LU0320765489.SGD","LU2089984988.USD","LU2491050154.USD","LU0823416689.USD","LU1989772923.USD","PPH","LU0070302665.USD","AMGN","LU2361045086.USD","LU1989772840.SGD","LU1917777945.USD","YMAX","LU2106854487.HKD","LU2360032135.SGD","LU1934455277.USD","LU0689626769.HKD","IE00BSNM7G36.USD","LU1093756168.USD","RXL","XLI","LU2242652126.USD","MYMmain","DJIA","SG9999014567.USD","LU0942090050.USD","LU1983299246.USD","LU0965509283.SGD","LU0130102774.USD","IE00BLSP4239.USD","BK4534","LU0109394709.USD","LU2125154935.USD","DVY","LU1066051225.USD","LU0130517989.USD","TBXU","LU2023250504.SGD","DGRO","LU0203347892.USD","DOG","LU1061106388.HKD","VYMI","BK4581","TOPT","LU0265550359.USD","LU0985320562.USD","IE00BFTCPJ56.SGD","SCHD","LU0266013472.USD","LU1023059063.AUD",".DJI","IE00B1BXHZ80.USD","PBE","LU0648001328.SGD","LU0122379950.USD","LU1035773651.USD","FDN","DDM","SG9999001176.SGD","LU1989771016.USD","LU2433249047.HKD","SG9999014575.USD","SG9999002232.USD","IE00B4R5TH58.HKD","SG9999015341.SGD","LU1201861249.SGD","IXJ","LU0211331839.USD","LU2112291526.USD","SG9999002224.SGD","LU1923622614.USD","IYH","BMED","SG9999015358.SGD","LU0289739699.SGD","BK4559","BK4566","SCHG","DXD","IE00BJT1NW94.SGD","LU0868494708.USD","LU2361044865.SGD","HRTS","SDOW","VYM","PAWZ","LU1162221912.USD","LU1941712348.USD","PJP","BK4599","GRNY","BK4588","LU1934455863.HKD","SGXZ57979304.SGD","MRK","IHE","LU1699723380.USD","BK4139","DGRW","LU1093756325.SGD","VUG","LU0006306889.USD","LU2491049909.HKD","DIA","LU0124676726.USD","LU2468319806.SGD","LU0477156953.USD","IBB","LU2023250843.SGD","IE00BBT3K403.USD","BK4533","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","LU1066051498.USD","FDVV","BK4550","BK4585","LU1571399168.USD","LU1037948897.HKD","LU2361044949.HKD","VHT","LU2357627491.SGD","SG9999001176.USD","LU1291159041.SGD","SG9999014542.SGD","FHLC","LU0980610538.SGD","LU1929549753.HKD","LU2461242641.AUD","TRUH","BK4516","IBBQ","LU0238689110.USD","LU0320765646.SGD","LU0432979614.USD","LU1116320737.USD","BBH","LU2242646821.SGD","BK4007","IE00B2B36J28.USD","LU1430594728.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU1069347547.HKD","IE0009355771.USD","LU1934455194.USD","DJX","SG9999013999.USD","LU0965509010.AUD","LU0098860793.USD","LU1941712264.USD","LU0058720904.USD","FTXH","LU0889565916.HKD","LU2125154778.USD","IE0002141913.USD","LU2324357040.USD","LU2125909593.SGD","LU2125909247.SGD","IE00BN8TJ469.HKD","GDOC","LU0234572021.USD","SG9999014559.SGD","LU0965509101.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660142854","title":"BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142854","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142854?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:04","pubTimestamp":1787141066,"startTime":"0","endTime":"0","summary":"BetterLife Pharma names Mahan Chehrenama chief medical officerBetterLife Pharma named Mahan Chehrenama as chief medical officer to lead clinical development of BETR-001.BETR-001 is advancing toward an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL40h7WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0058720904.USD","IBB","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0122379950.USD","BK4588","IE00B4R5TH58.HKD","PJP","IE00BJJMRZ35.SGD","LU2242652126.USD","TBXU","SG9999001440.SGD","BBH","LU1061106388.HKD","AMGN","LU1571399168.USD","BK4581","BK4566","LU1057294990.SGD","BIB","IE0002141913.USD","LU0289739699.SGD","IBBQ","BK4599","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0320765992.SGD","LU2242646821.SGD","LU2468319806.SGD","LU2112291526.USD","LU0109394709.USD","PBE","BK4534","LU1983299246.USD","IE0009355771.USD","BK4139","LU0868494617.USD","BK4533","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660344705","title":"Amgen Inc : Argus Research Raises Target Price to $460","url":"https://stock-news.laohu8.com/highlight/detail?id=2660344705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660344705?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:25","pubTimestamp":1787138742,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","LU1571399168.USD","LU1023059063.AUD","TBXU","BK4581","BK4139","IE00BFTCPJ56.SGD","BK4534","LU2112291526.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4588","PJP","LU2242652126.USD","LU0868494617.USD","SG9999001440.SGD","IBB","LU0122379950.USD","BK4566","LU2089984988.USD","BK4533","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BIB","BK4585","LU1061106388.HKD","LU1983299246.USD","LU2242646821.SGD","PBE","LU0320765992.SGD","LU0058720904.USD","LU1057294990.SGD","AMGN","LU0289739699.SGD","IE0009355771.USD","BK4599","IE0002141913.USD","IBBQ","IE00BJJMRZ35.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660417405","title":"What This Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2660417405","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660417405?lang=en_us&edition=fundamental","pubTime":"2026-08-19 14:30","pubTimestamp":1787121000,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","LU2462157665.USD","LU0353189680.USD","IE0009355771.USD","LU2468319806.SGD","LU0889566641.SGD","LU1037948897.HKD","LU2242646821.SGD","LU0170899867.USD","LU1732799900.SGD","LU1162221912.USD","LU2168563687.JPY","LU0823416689.USD","SGXZ99366536.SGD","BK4504","IE00B775H168.HKD","IE00BN0W2V16.EUR","LU2028103732.USD","IE000SO60NU8.SGD","IE00BZ9MQY76.HKD","LU0683600562.USD","JNJ","LLYX","IE00BVYPNV92.GBP","IE00BK4W5L77.USD","LU2023250504.SGD","LU2213496289.HKD","IE00B1XK9C88.USD","LU1868836757.USD","LU2063271972.USD","LU2746668461.USD","HRTS","LU2491050071.SGD","IE00BWXC8680.SGD","LU0158827948.USD","LLII","LU1066053197.SGD","LU2602419157.SGD","TMED","LU1548497426.USD","BK4567","LU2505996681.GBP","LU0289739699.SGD","SG9999011175.SGD","LU0426412945.USD","LU2237443549.SGD","LU2362541273.HKD","SG9999014914.USD","LU0882574139.USD","LU1061106388.HKD","LU1929549753.HKD","SG9999015952.SGD","LU0203202063.USD","IE0002141913.USD","BK4550","BK4533","XBI","LU2237443622.USD","IE00BKPKM429.USD","LU0069063385.USD","LU2106854487.HKD","LU0128525929.USD","SG9999001176.USD","TRUH","LU0820562030.AUD","BIB","LU0154245756.USD","WDNA","LU0133085943.USD","LU2237438978.USD","LU0198837287.USD","LU1043141396.HKD","LU1127390331.HKD","LU2750360997.AUD","LU0792757196.USD","LU1093756325.SGD","LU1506573853.SGD","LU1934455277.USD","IE000F7OJYX1.SGD","LU0471298694.HKD","LU1291159041.SGD","LU2487616109.SGD","LU2361044949.HKD","LU1074936037.SGD","LU0354030511.USD","IE00B19Z9Z06.USD","LU1228905540.USD","LU0820561818.USD","LU0964807845.USD","LU0097036916.USD","BBH","LU2237443465.HKD","LU2129689514.USD","LU0109391861.USD","LU0787776722.HKD","BK4583","BK4559","LU1032955483.USD","LU1670628061.USD","LU1989772923.USD","BMED","LU2361045086.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU0029864427.USD","BK4578","IE00BJJMRY28.SGD","LU1043141123.HKD","LU1232071149.USD","BK4581","IE0004445239.USD","LU0234570918.USD","BK4592","LU2362540622.SGD","IE00BJJMRZ35.SGD","REGN","LU0949170772.SGD","IE00BLSP4239.USD","LU2089283258.USD","LU0098860793.USD","SG9999001176.SGD","CURE","LU1035775433.USD","IE000WAW04H5.SGD","LU0158827781.USD","LU1267930813.SGD","XLV","IHE","LU0094547139.USD","LU1989772840.SGD","LU2347655073.USD","LU0057025933.USD","GB00BDT5M118.USD","IE00BN0W2T93.GBP","IBB","IE00BGHQF631.EUR","LU1037948541.HKD","IE00B3PB1722.GBP","LU2324357040.USD","LU0994945656.USD","LU2023251221.USD","PBE","LU1935042991.SGD","IE00B3T34201.USD","LU1267930730.SGD","LU1623119135.USD","IE00BBT3K403.USD","LU0310800379.SGD","LU2756315318.SGD","LU0726765562.USD","LU1778281490.HKD","LU1718418525.SGD","LU1280957306.USD","LU0965509101.SGD","BK4566","LU2756315664.SGD","AMGN","IE000MB6IJN5.SGD","IE00BFSS7M15.SGD","LU0320765059.SGD","IE00BSNM7G36.USD","LU0985320562.USD","LU2347655156.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","SG9999001440.SGD","BK4588","BK4532","BK4568","LU0795875169.SGD","LU2087625088.SGD","LU1923622614.USD","GNMX","LU2362541513.USD","LU0965509010.AUD","LU0211327993.USD","LU1496350502.SGD","CANC","LU0345769128.USD","LU1983299246.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","MEDX","IE00BDGV0183.EUR","LU1003077747.HKD","LU1496350171.SGD","IE00B4JS1V06.HKD","SG9999013999.USD","BK4534","GLAM","LU0385154629.USD","LU2211815571.USD","LU1066051811.HKD","LU0426417589.USD","LU0203201768.USD","LU2552382132.HKD","LU0965509283.SGD","TBXU","IXJ","LU1093756168.USD","LU1670627923.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","ILDR","LU0072461881.USD","LU0889565916.HKD","LU0466842654.USD","LU1267930573.SGD","BK4007","LU1814569148.SGD","VRTX","IE00BK4W5M84.HKD","SGXZ81514606.USD","LU2456880835.USD","LU1934455194.USD","JDOC","IE0004445015.USD","LU1914381329.SGD","LU0124676726.USD","LU0823434740.USD","LU1059921491.USD","LU1121112475.USD","IE000BZT7R73.USD","IE00BJLML261.HKD","LU2236285917.USD","LU0162691827.USD","LU0210528500.USD","LU0316494557.USD","LU1712237335.SGD","LU0096364046.USD","LU2242652126.USD","LU1988902786.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","SG9999018865.SGD","PPH","LU2237443895.HKD","OZEM","IE00B4R5TH58.HKD","LU0689626769.HKD","LU1979441026.SGD","LU1894683348.USD","LU2271345857.HKD","LU0395794307.EUR","LU2357627491.SGD","SG9999002232.USD","LU0456855351.SGD","LU2471134952.CNY","LU2357305700.SGD","LU2087621335.USD","LU2265009873.SGD","FHLC","JAZZ","LU2264538146.SGD","IE0000B7K699.USD","LU2168564495.EUR","LU1894683264.USD","PJP","LU0553294199.USD","LU1868836914.USD","LU2433249047.HKD","XDNA","LU0289739343.SGD","LU2168564222.USD","LU0006306889.USD","IE00BZ1G4Q59.USD","LU0672654240.SGD","LU1917777945.USD","LU0965508806.USD","LU2491050154.USD","LU1145028129.USD","LU0472753341.HKD","LU1720051108.HKD","LU2461242641.AUD","LU0545039389.USD","LU0786609619.USD","LLY","LU0256863902.USD","SG9999014898.SGD","BK4139","LU0203347892.USD","04332","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU0061475181.USD","LU0861579265.USD","LU0345770993.USD","LU2237443978.SGD","SG9999017495.SGD","BK4516","IBBQ","IE000M9KFDE8.USD","LU1057294990.SGD","LU2403377893.USD","VHT","LU2089284900.SGD","LU2471134879.HKD","LU2430703095.HKD","LU1323610961.USD","LU0320765646.SGD","LU2361044865.SGD","LU2430703178.SGD","LU1066051225.USD","LU0640476718.USD","LU0079474960.USD","THNR","LU1720051017.SGD","IE00BN29S564.USD","LU1868837300.USD","ABBV","LU1804176565.USD","SGXZ31699556.SGD","IE0002270589.USD","RXL","IE00BN0W2W23.USD","LU2168564149.EUR","LLYZ","LU2750360641.GBP","IE00BVYPNW00.USD","LU2896262040.SGD","LU0417517546.SGD","LU2125909247.SGD","LU1267930490.SGD","IE00BFSS8Q28.SGD","LU1868836591.USD","IYH","LU0942090050.USD","IE00BFXG1179.USD","LU0234572021.USD","LU1196500208.SGD","LU0174119429.USD","LU2129689605.HKD","LU0882574055.USD","LU1674673428.USD","LU2111349929.HKD","MEDI","LU2746668974.SGD","LU2552382215.SGD","LU0738911758.USD","LU2430703251.USD","LU1221951129.SGD","IE00B2B36J28.USD","BK4599","LU2471134523.USD","LU1732800096.USD","LU0868494708.USD","LU0345770308.USD","SG9999014880.SGD","FTXH","MHIP","LU0210536198.USD","IE00BN8TJ469.HKD","LU1839511570.USD","LU1430594728.SGD","LU1261432733.SGD","LU1244550577.SGD","LU1674673691.USD","LU2491049909.HKD","LU0310799852.SGD","LU1066051498.USD","LU0353189763.USD","LU2592432038.USD","LU2108987350.USD","LU1366192091.USD","AGNG","LU0545562505.USD","SG9999014906.USD","LU2237443382.USD","LU0943347566.SGD","LU0122379950.USD","LU0820561909.HKD","LU2125909593.SGD","IE00B19Z9P08.USD","IE00B1BXHZ80.USD","LU0823434583.USD","LU1064131342.USD","LU1629891620.HKD","LU0154245673.USD","GILD","SG9999015945.SGD","LU2112291526.USD","ELIL","LU0795875086.SGD","LU0511384066.AUD","LU1244550221.USD","LU2023250330.USD","LU0070217475.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU1023059063.AUD","LU0289961442.SGD","LU1551013342.USD","LU1244550494.USD","LU0106261372.USD","LU0203345920.USD","IE00BJJMRX11.SGD","ELIS","LU0912757837.SGD","SGXZ57979304.SGD","LU0471298777.SGD","LU2462591350.SGD","LU0320765992.SGD","LU0109394709.USD","LU1032466523.USD","LU0708994859.HKD","LU0859254822.USD","SGXZ80539844.SGD","SG9999015978.USD","IE00BKDWB100.SGD","IE00B42XCP33.USD","LU0058720904.USD","LU0868494617.USD","LU1974910355.USD","LU2129689431.USD","SG9999018857.SGD","LU0211328371.USD","LU2552382058.USD","LU0345769631.USD","SGXZ51526630.SGD","LU0256863811.USD","LU0323591593.USD","LU1585245621.USD","LU0661504455.SGD","LU1221951046.USD","LU0114720955.EUR","LU2417539215.USD","IE00B894F039.SGD","BK4585","LU2471134796.USD","IDNA","LU2133065610.SGD","LU0432979614.USD","IE00B19Z3581.USD","SG9999015986.USD","LU0354030438.USD","LU2360106947.USD","LU0053666078.USD","LU1069344957.HKD","LU2089984988.USD","LU1989771016.USD","LU1868837136.USD","IE0001KFT4U8.USD","LU0689472784.USD","LU2168564065.EUR","LU0225283273.USD","IE0034235303.USD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490195","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490195","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490195?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:54","pubTimestamp":1787093684,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier disposes of USD 3.86 million in common sharesGilead Chief Communications and Corporate Affairs Officer Johanna Mercier exercis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbJPzzx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0122379950.USD","IBB","IE00BZ1G4Q59.USD","LU0882574055.USD","LU0114720955.EUR","LU1066053197.SGD","LU0965509010.AUD","LU1674673428.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0234570918.USD","BIB","BMED","LU0320765992.SGD","IE00B7SZLL34.SGD","TMED","IBBQ","BBH","LU1430594728.SGD","SG9999015986.USD","LU1585245621.USD","TBXU","BK4583","BK4139","BK4585","LU2468319806.SGD","BK4566","LU2089984988.USD","LU0889565916.HKD","LU0965509101.SGD","LU1037948541.HKD","LU1057294990.SGD","LU2112291526.USD","LU2087621335.USD","LU0823416689.USD","BK4588","LU0965509283.SGD","GILD","BK4532","LU0058720904.USD","BK4550","LU1066051498.USD","IE00B19Z3581.USD","LU0861579265.USD","MEDI","IE00B19Z3B42.SGD","LU1674673691.USD","LU1934455277.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497970","title":"TScan Therapeutics Faces Loss of Key Amgen Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497970","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497970?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:32","pubTimestamp":1787088742,"startTime":"0","endTime":"0","summary":"TScan Therapeutics ( ($TCRX) ) has shared an announcement. On August 12, 2026, TScan Therapeutics said that Amgen had exercised its right to termin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-faces-loss-of-key-amgen-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-faces-loss-of-key-amgen-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TCRX","BK4539","IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","LU0058720904.USD","AMGN","LU0889565916.HKD","BIB","LU2242652126.USD","BK4588","PJP","LU1023059063.AUD","LU2112291526.USD","LU0868494617.USD","LU0289739699.SGD","BK4599","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","IBB","LU0320765992.SGD","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","TBXU","BK4007","BK4533","SG9999001440.SGD","BK4566","BK4139","IE0002141913.USD","BK4581","LENZ","BK4534","BK4585","LU1571399168.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492015","title":"TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492015?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:03","pubTimestamp":1787086998,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F15X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4588","BK4139","IE00B2B36J28.USD","TCRX","BK4581","PJP","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU2089984988.USD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0109394709.USD","BK4539","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","TBXU","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492601","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492601?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:36","pubTimestamp":1787085360,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 3.25% to $143.44 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.69% to 7,691.76 and Dow Jones Industrial Average  falling 0.22% to 53,343.40.This was the stock's sixth consecutive day of gains.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 3.33% to $271.11, Pfizer Inc.  rose 1.41% to $27.25, and Abbott Laboratories  rose 2.09% to $112.68.Trading volume  remained 1.9 million below its 50-day average volume of 7.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","SG9999015978.USD","LU2087621335.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1839511570.USD","LU1934455194.USD","LU0965509101.SGD","LU0882574055.USD","LU0965508806.USD","BK4578","BK4583","IBB","LU0965509010.AUD","LU1934455863.HKD","TBXU","LU0823416689.USD","LU1585245621.USD","IE00B3T34201.USD","LU1430594728.SGD","LU2324357040.USD","MEDI","LU0289739699.SGD","LU0234570918.USD","LU0320765992.SGD","SG9999015986.USD","LU1571399168.USD","LU1674673428.USD","SG9999015952.SGD","GILD","BK4588","BMED","BK4568","LU1023059063.AUD","LU0122379950.USD","BK4550","LU0058720904.USD","LU0861579265.USD","LU2089984988.USD","BIB","IE00B7SZLL34.SGD","LU1061106388.HKD","BK4139","LU0109394709.USD","LU2112291526.USD","IBBQ","IE00BSNM7G36.USD","LU0965509283.SGD","BK4532","LU1066053197.SGD","LU1674673691.USD","LU0114720955.EUR","LU1066051498.USD","TMED","IE00B19Z3581.USD","IE0002270589.USD","BK4585","LU0889565916.HKD","SG9999015945.SGD","BK4566","LU1037948541.HKD","LU1934455277.USD","IE00BZ1G4Q59.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492411","title":"BMO starts Exelixis at Market Perform into patent cliff","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492411?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:30","pubTimestamp":1787085023,"startTime":"0","endTime":"0","summary":"BMO Capital initiated coverage of Exelixis (EXEL) with a Market Perform rating and $54 price target Exelixis is anchored by cabozantinib, a “durabl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRUH","USRD","JDOC","EXEL","LU2272731782.SGD","BK4585","LU1992135472.HKD","BK4139","XPH","BK4207","LU2272731600.USD","LU2272731865.HKD","IHE","BBH","IE00B5TLWC47.USD","LU2322448957.HKD","MEDI","MEDX","PTH","APXH","FTXH","BK4588","GSKH","BMO","IYH","SYNB","LU2322448791.USD","BK4532","LU2473716301.USD","TMED","FHLC","PBPH","PJP","CURE","IBB","AZNH","FBT","LU1992135399.USD","RSPH","BME","RXL","PPH","RXD","FXH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}